Veracyte, Inc. (VCYT): Price and Financial Metrics

Veracyte, Inc. (VCYT)

Today's Latest Price: $29.34 USD

0.99 (3.49%)

Updated Dec 5 11:36am

Add VCYT to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 326 in Biotech

See all "A" rated Strong Buy stocks

VCYT Stock Summary

  • With a price/sales ratio of 9.99, Veracyte Inc has a higher such ratio than 89.47% of stocks in our set.
  • VCYT's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 12.62% of US stocks.
  • With a year-over-year growth in debt of -44.78%, Veracyte Inc's debt growth rate surpasses just 6.96% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to Veracyte Inc, a group of peers worth examining would be NVRO, CDLX, IRTC, AMRN, and EXAS.
  • Visit VCYT's SEC page to see the company's official filings. To visit the company's web site, go to
VCYT Daily Price Range
VCYT 52-Week Price Range

VCYT Stock Price Chart More Charts

VCYT Price/Volume Stats

Current price $29.34
Prev. close $28.34
Day low $28.37
Day high $29.41
50-day MA $24.73
200-day MA $25.03
52-week high $31.18
52-week low $10.73
Volume 199,264
Avg. volume 641,753
Dividend yield N/A
Market Cap 1.43B

Veracyte, Inc. (VCYT) Company Bio

Veracyte Inc. operates as a molecular diagnostics company in the United States. It operates in the field of molecular cytology with genomic solutions that resolve diagnostic ambiguity and enable physicians to make informed treatment decisions at an early stage in patient care. The company was founded in 2006 and is based in San Francisco, California.

VCYT Latest News Stream

Event/Time News Detail
Loading, please wait...

VCYT Latest Social Stream

Loading social stream, please wait...

View Full VCYT Social Stream

VCYT Price Returns

1-mo 22.20%
3-mo 14.30%
6-mo 13.94%
1-year N/A
3-year 281.04%
5-year 337.26%
YTD 133.23%
2018 92.65%
2017 -15.63%
2016 7.50%
2015 -25.47%
2014 -33.38%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5645 seconds.